Business strategy
Agile. International. High-performing.
Every year we strive to improve therapies by reliably supplying millions of doses of our products across a wide range of therapeutic classes.
In the rest of the world, we deliver our top products through a consolidated network of strategic international & local partners.
We currently market over 250 products globally, with an active pipeline of new ones always on the way. We have adopted two different business models to manage daily challenges and leverage opportunities for growth. In Switzerland, Germany and Austria our specialized national sales teams directly promote and market our products. Worldwide the International division delivers our top medicines throughout strategic international partners.
Business
Development
We offer a dynamic portfolio of selected branded and generic products, developed to address certain niche and unmet clinical needs. We strive to build strong and long-lasting successful alliances with our international partners.
Business
Overview
Sintetica is a fast-growing specialty pharma company fully integrated from R&D and production to distribution. While having established our direct business, we also leverage on strategic partnerships.
Value Proposition
All our medicines are manufactured and controlled under strict quality and safety measures, meeting the highest Swiss, European, US and international standards. Sintetica boasts a state-of-the-art, FDA-approved production facility in Switzerland with low saturation and best-in-class manufacturing know-how.
Sintetica delivers its distinctive value proposition through:
⎯⎯ Privileged connection to all Swiss hospitals
⎯⎯ Continuous innovation based on deep understanding of medical needs
⎯⎯ Excellent inroads into key markets of Germany, Austria and the USA
⎯⎯ Quality without compromises on the entire production
⎯⎯ An agile and empowered organization founded on responsibility and merit
⎯⎯ Strategic partnerships along the whole Value Chain based on shared values
⎯⎯ Well established global network of partners in multiple markets across the globe
⎯⎯ Top Quality products manufactured in Switzerland
⎯⎯ Consistency in supply thanks to flexible manufacturing and short supply chain
Our organisational capabilities
Each individual in Sintetica is crucial.
Along every single step of our Value Chain, we strive to make the difference to accomplish our mission and pursue continuous improvement. Customer focus and innovation, inspiring leadership, agility and speed are the key axes on which we base our work every day.
-
By improving the way therapies are formulated and used, we can have the biggest impact. We engage with customers and clinicians to understand unmet needs.
We think outside the box, challenge the status quo and accelerate the adoption of new solutions to improve therapies and make an impact.
We combine our research and development, industrial, clinical and medical people in an innovation cluster, creating a collaborative and creative work environment.
-
Our experienced R&D department with 30+ dedicated professionals (more than 15% of the total workforce of our HQ), has developed a portfolio of 16 patents over the last years.
With a proven track record of innovation and a visible pipeline, we are ready for new launches in Europe, the US and the rest of the world between 2023 and 2025.
-
A keen focus on top-notch deliverables to provide outstanding scientific value to all our programs and products.
We liaise with partners, health authorities, healthcare professionals and other relevant stakeholders to satisfy every requirement and respond to requests quickly and efficiently.
A full-fledged, highly experienced team of regulatory, clinical, pre-clinical and pharmacovigilance professionals with a solid track record and an average of 50+ marketing authorizations p.a. completed worldwide over the last years.
-
Our commitment is to apply the highest quality standards (Good Manufacturing Practices - GMP, FDA 21 CFR Part 210/211, International Council for Harmonisation - ICH, Pharmaceutical Inspection Convention / Cooperation Scheme – PIC / S, PE 009 “Guide to Good Manufacturing Practice for medicinal products”, national and international Pharmacopoeia) to ensure our products meet all quality, efficacy, and safety requirements during the entire life cycle.
Our mission involves devoting the utmost attention to guarantee that our products provide the desired effect to the patients and are fit for their intended use.
-
Our two cutting-edge manufacturing facilities, located in Switzerland, ensure reliable and high-quality products to all our partners and patients worldwide.
Top-tier technology ensures smooth flow of all production processes increasing the output per man-hour and facilitating the working practice of all our workers by eliminating bottlenecks.
-
Customer satisfaction is the pillar on which our supply chain is founded.
Everyone operating in the planning, logistics and purchasing management works together to ensure efficiency and on-time in-full delivery.
We always make sure that the maximum attention to ethical and environmentally responsible practices is included into our business model.
-
Our commitment to innovate therapies and drugs in anaesthesia, pain management & intensive care requires us to bring efficiently and effectively millions of doses of our life-saving products to the healthcare professionals fighting to save lives of critically ill patients. Our commercial structure has been set up to reach these objectives.
Our Marketing & Sales team is fully committed to regularly interact with healthcare professionals and our alliance partners to identify unmet needs and areas requiring further support. Our team frequently provides necessary product safety and efficacy information and product training to the healthcare professionals. The team is always available to answer any questions in order to improve patient treatment day after day.
We bring our portfolio of more than 250 products to patients in more than 50 countries through our own teams or through our valued alliance partners. Our team is present on the ground in Switzerland, Germany and Austria and contacts the healthcare professionals directly. In multiple other markets we work through our valued alliance partners with whom we have long-established agreements to commercialize our products. We continuously strive to improve our market reach through further strengthening our presence and alliances.
-
For Sintetica, a team of highly motivated, competent, and responsible employees endowed with autonomy is a decisive factor for business growth.
The HR department is responsible for securing the best actors in developing the company's business and ensuring effective human capital management that combines corporate interests with personal ambitions and well-being.
-
At Sintetica we have the ambition to pioneer digital transformation in the space where we operate. We are fully committed to implement best in class systems and solutions to support our patients and ensure a sustainable business growth.
The digital roadmap is a fundamental pillar of the company strategy to empower our people and our ability to innovate. Each employee is invited to actively participate in this important change which will further increase our quality levels and will create new opportunities for everyone.
-
We have a range of capabilities and high-performing experts across finance and corporate governance.
Our experienced departments are deeply committed to operating in compliance with applicable laws and standards.
